Literature DB >> 23661654

Nitrofurantoin: cause of DRESS syndrome.

Rodrigo Nazário Leão1, Paulo Barreto, Ricardo R Leão, José Vaz Ribeiro.   

Abstract

Urinary tract infections (UTIs) are a common pathological entity among elderly patients. The widespread use of antibiotics for uncomplicated UTIs has gained many opponents mainly due to the increasing drug resistance observed. Nitrofurantoin is a commonly used antibacterial drug because it has low side effects and a good antiurinary bacterial profile. However, in this paper, we present a case of a nitrofurantoin-induced DRESS (drug reaction/rash with eosinophilia and systemic symptoms) syndrome in a 77-year-old woman. During UTI treatment, the patient developed an acute skin rash which spread all over the body and a considerable decrease in urine volume. At the emergency department, we found her developing eosinophilic pneumonia, anaemia and renal impairment that we relate to nitrofurantoin administration. To our knowledge, this is the second published case report which evokes nitrofurantoin as a possible cause of DRESS syndrome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23661654      PMCID: PMC3669827          DOI: 10.1136/bcr-2013-008991

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  17 in total

1.  [Management of drug reaction with eosinophilia and systemic symptoms (DRESS)].

Authors:  V Descamps; B Ben Saïd; B Sassolas; F Truchetet; M Avenel-Audran; P Girardin; M-T Guinnepain; P Mathelier-Fusade; H Assier; B Milpied; P Modiano; B Lebrun-Vignes; A Barbaud
Journal:  Ann Dermatol Venereol       Date:  2010-08-05       Impact factor: 0.777

2.  Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

Authors:  S H Kardaun; A Sidoroff; L Valeyrie-Allanore; S Halevy; B B Davidovici; M Mockenhaupt; J C Roujeau
Journal:  Br J Dermatol       Date:  2007-03       Impact factor: 9.302

3.  High-dose intravenous immunoglobulin monotherapy for drug-induced hypersensitivity syndrome.

Authors:  Yukiko Kito; Taisuke Ito; Yoshiki Tokura; Hideo Hashizume
Journal:  Acta Derm Venereol       Date:  2012-01       Impact factor: 4.437

4.  Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?

Authors:  I Garcia-Doval; L LeCleach; H Bocquet; X L Otero; J C Roujeau
Journal:  Arch Dermatol       Date:  2000-03

Review 5.  Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.

Authors:  Pierre-Dominique Ghislain; Jean-Claude Roujeau
Journal:  Dermatol Online J       Date:  2002-06

6.  Comparison of the causes and clinical features of drug rash with eosinophilia and systemic symptoms and stevens-johnson syndrome.

Authors:  Yun-Jin Jeung; Jin-Young Lee; Mi-Jung Oh; Dong-Chull Choi; Byung-Jae Lee
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-24       Impact factor: 5.764

7.  A 6-month prospective survey of cutaneous drug reactions in a hospital setting.

Authors:  F Fiszenson-Albala; V Auzerie; E Mahe; R Farinotti; C Durand-Stocco; B Crickx; V Descamps
Journal:  Br J Dermatol       Date:  2003-11       Impact factor: 9.302

Review 8.  Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review.

Authors:  Maria Ganeva; Tanya Gancheva; Roumiana Lazarova; Jeni Troeva; Ivan Baldaranov; Ivan Vassilev; Evgenya Hristakieva; Valentina Tzaneva
Journal:  Int J Dermatol       Date:  2008-08       Impact factor: 2.736

9.  The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 Reactivation.

Authors:  Joshua C Pritchett; Radu M Nanau; Manuela G Neuman
Journal:  Int J Hepatol       Date:  2012-05-16

10.  Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist?

Authors:  Sophie Bouvresse; Laurence Valeyrie-Allanore; Nicolas Ortonne; Marie Pauline Konstantinou; Sylvia H Kardaun; Martine Bagot; Pierre Wolkenstein; Jean-Claude Roujeau
Journal:  Orphanet J Rare Dis       Date:  2012-09-25       Impact factor: 4.123

View more
  5 in total

Review 1.  Eosinophilic Drug Allergy.

Authors:  Merin Kuruvilla; David A Khan
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 10.817

2.  Drug reaction with eosinophilia and systemic symptoms syndrome associated with Nitrofurantoin.

Authors:  Jitendra Singh; Anju Dinkar; Virendra Atam; Kamlesh K Gupta; Krishna Kumar Sahani
Journal:  J Res Pharm Pract       Date:  2016 Jan-Mar

Review 3.  Eosinophils from Physiology to Disease: A Comprehensive Review.

Authors:  Giuseppe A Ramirez; Mona-Rita Yacoub; Marco Ripa; Daniele Mannina; Adriana Cariddi; Nicoletta Saporiti; Fabio Ciceri; Antonella Castagna; Giselda Colombo; Lorenzo Dagna
Journal:  Biomed Res Int       Date:  2018-01-28       Impact factor: 3.411

4.  Pulmonary Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review.

Authors:  Pahnwat Tonya Taweesedt; Charles W Nordstrom; Jessica Stoeckel; Igor Dumic
Journal:  Biomed Res Int       Date:  2019-09-24       Impact factor: 3.411

Review 5.  Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review.

Authors:  Shiva Sharifzadeh; Amir Hooshang Mohammadpour; Ashraf Tavanaee; Sepideh Elyasi
Journal:  Eur J Clin Pharmacol       Date:  2020-10-06       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.